Revance Therapeutics (RVNC) Earnings Date, Estimates & Call Transcripts

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free rvnc Stock Alerts

$3.79

+0.03 (+0.80%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 14Estimated
Actual EPS (Feb. 28): -$0.62 Beat By $0.17
Consensus EPS (Feb. 28): -$0.79

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

RVNC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RVNC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Revance Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	($0.69)	($0.56)	($0.63)
Q2 2024	2	($0.59)	($0.56)	($0.58)
Q3 2024	2	($0.66)	($0.49)	($0.58)
Q4 2024	2	($0.55)	($0.43)	($0.49)
FY 2024	8	($2.49)	($2.04)	($2.27)
Q1 2025	1	($0.49)	($0.49)	($0.49)
Q2 2025	1	($0.26)	($0.26)	($0.26)
Q3 2025	1	($0.26)	($0.26)	($0.26)
Q4 2025	1	($0.20)	($0.20)	($0.20)
FY 2025	4	($1.21)	($1.21)	($1.21)

RVNC Earnings Date and Information

Revance Therapeutics last issued its earnings data on February 28th, 2024. The biopharmaceutical company reported ($0.62) EPS for the quarter, beating analysts' consensus estimates of ($0.79) by $0.17. The business earned $69.80 million during the quarter, compared to analysts' expectations of $64.02 million. Revance Therapeutics has generated ($3.79) earnings per share over the last year (($3.79) diluted earnings per share). Earnings for Revance Therapeutics are expected to grow in the coming year, from ($2.17) to ($1.13) per share. Revance Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Revance Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/14/2024 Estimated)	-	-	-	-	-	-	-
2/28/2024	Q4 2023	($0.79)	($0.62)	+$0.17	($0.62)	$64.02 million	$69.80 million
11/8/2023	Q3 2023	($1.02)	($0.74)	+$0.28	$0.15	$58.49 million	$56.78 million
8/8/2023	Q2 2023	($0.72)	($0.80)	($0.08)	($0.80)	$58.71 million	$58.13 million
5/9/2023	Q1 2023	($0.75)	($0.74)	+$0.01	($0.74)	$46.21 million	$49.33 million
2/28/2023	Q4 2022	($1.04)	($1.82)	($0.78)	($1.82)	$45.10 million	$49.90 million
11/8/2022	Q3 2022	($0.85)	($1.17)	($0.32)	($1.17)	$28.76 million	$29.02 million
Get the Latest News and Ratings for RVNC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/9/2022	Q2 2022	($0.91)	($0.88)	+$0.03	($0.88)	$27.64 million	$28.37 million
5/10/2022	Q1 2022	($0.91)	($0.94)	($0.03)	($0.94)	$23.55 million	$25.26 million
2/28/2022	Q4 2021	($0.98)	($0.93)	+$0.05	($0.93)	$24.56 million	$25.95 million
11/9/2021	Q3 2021	($1.15)	($1.10)	+$0.05	($1.10)	$20.03 million	$19.75 million
8/5/2021	Q2 2021	($1.14)	($1.07)	+$0.07	($1.07)	$16.68 million	$18.80 million
5/10/2021	Q1 2021	($1.19)	($1.08)	+$0.11	($1.08)	$12.44 million	$13.30 million

Revance Therapeutics Earnings - Frequently Asked Questions

When is Revance Therapeutics's earnings date?: Revance Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on RVNC's earnings history.
Did Revance Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Revance Therapeutics (NASDAQ:RVNC) reported ($0.62) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.17. Learn more on analysts' earnings estimate vs. RVNC's actual earnings.
How can I listen to Revance Therapeutics's earnings conference call?: The conference call for Revance Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Revance Therapeutics's conference call transcript?: The conference call transcript for Revance Therapeutics's latest earnings report can be read online. Read Transcript
How much revenue does Revance Therapeutics generate each year?: Revance Therapeutics (NASDAQ:RVNC) has a recorded annual revenue of $234.04 million.
How much profit does Revance Therapeutics generate each year?: Revance Therapeutics (NASDAQ:RVNC) has a recorded net income of -$323.99 million. RVNC has generated -$3.79 earnings per share over the last four quarters.
What is Revance Therapeutics's EPS forecast for next year?: Revance Therapeutics's earnings are expected to grow from ($2.17) per share to ($1.13) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:RVNC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Revance Therapeutics (RVNC) Earnings Date, Estimates & Call Transcripts

RVNC Earnings Estimates and Actuals by Quarter

RVNC Estimated and Actual Revenue by Quarter

Revance Therapeutics Analyst EPS Estimates

RVNC Earnings Date and Information

Revance Therapeutics Earnings History by Quarter

Revance Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Revance Therapeutics (RVNC) Earnings Date, Estimates & Call Transcripts

Earnings Summary

RVNC Earnings Estimates and Actuals by Quarter

RVNC Estimated and Actual Revenue by Quarter

Revance Therapeutics Analyst EPS Estimates

RVNC Earnings Date and Information

Revance Therapeutics Earnings History by Quarter

Revance Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat